- Record: found
- Abstract: not found
- Article: not found
Phase ib dose escalation study of novel immunogenic cell death (ICD) inducer PT-112 plus PD-L1 inhibitor avelumab in solid tumours
D Karp, R Dronca, R Camidge, B. COSTELLO, A Mansfield, T. AMES, J. Jimeno, A Bryce, D.D. Karp, R.S. Dronca, B.A. Costello, A.S. Mansfield, T.D. Ames, J.M. Jimeno, A.H. Bryce
2020
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.